Grown Rogue International (GRUSF) EBITDA Margin Growth (3y) (2012 - 2023)
Grown Rogue International (GRUSF) EBITDA Margin Growth (3y) (2012 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1,673.00 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -37.00 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -5,395.00 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -1,442.00 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -1,299.00 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 5,091.00 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5,193.00 |
| 10 | Grown Rogue International | 99.97 Mn | 92.67 Mn | 3.96 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2023 | 29,707.00 |
| Jul 31, 2023 | -6,961.00 |
| Apr 30, 2023 | 6,472.00 |
| Jan 31, 2023 | 3,042.00 |
| Jan 31, 2022 | 57,143.00 |
| Oct 31, 2021 | 24,916.00 |
| Jul 31, 2021 | 8,238.00 |
| Apr 30, 2021 | 29,865.00 |
| Jan 31, 2021 | 48,546.00 |
| Aug 31, 2014 | -1,961.00 |
| Aug 31, 2013 | 5,407.00 |
| May 31, 2013 | 206.00 |
| Feb 28, 2013 | -1,868.00 |
| Aug 31, 2012 | 76,741.00 |
| May 31, 2012 | -22,539.00 |
| Feb 29, 2012 | 6,003.00 |